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ABSTRACT
Single-stranded DNA-binding proteins (SSB) form a
class of proteins that bind preferentially single-
stranded DNA with high affinity. They are involved
in DNA metabolism in all organisms and serve a vital
role in replication, recombination and repair of DNA.
In this report, we identify human mitochondrial SSB
(HmtSSB) as a novel protein-binding partner of
tumour suppressor p53, in mitochondria. It binds
to the transactivation domain (residues 1–61) of
p53 via an extended binding interface, with dissoci-
ation constant of 12.7 (±0.7) kM. Unlike most bind-
ing partners reported to date, HmtSSB interacts
with both TAD1 (residues 1–40) and TAD2 (residues
41–61) subdomains of p53. HmtSSB enhances intrin-
sic 3’-5’ exonuclease activity of p53, particularly
in hydrolysing 8-oxo-7,8-dihydro-2’-deoxyguano-
sine (8-oxodG) present at 3’-end of DNA. Taken
together, our data suggest that p53 is involved in
DNA repair within mitochondria during oxidative
stress. In addition, we characterize HmtSSB binding
to ssDNA and p53N-terminal domain using various
biophysical measurements and we propose binding
models for both.
INTRODUCTION
Single-stranded DNA-binding proteins (SSBs) comprise a
group of proteins that bind preferentially to single-
stranded DNA (ssDNA) with high aﬃnity. SSBs do not
exhibit direct catalytic functions, but are key players in
DNA metabolism in all organisms (1). SSBs serve a vital
role in replication (2), recombination (3) and repair of
DNA (4) by binding to intermediate ssDNA products,
thereby protecting them from refolding or nucleolytic
attacks. Several groups of SSBs can be classiﬁed based
on sequence comparisons. Viral proteins [e.g. T4 gene 32
protein (5), gene 5 protein from ﬁlamentous phages (6)]
diﬀer considerably from prokaryotic SSBs [e.g. SSBs from
Escherichia coli (7)] and several F-plasmids from E. coli
(8). Eukaryotic SSBs are subdivided into two categories,
nuclear and mitochondrial SSBs. Nuclear SSBs (RPA)
have been found in all eukaryotic cells examined (9).
These proteins are essential for replication of chromo-
somal DNA (10). Moreover, they interact speciﬁcally
with other proteins involved in DNA metabolism. These
proteins, however, do not have any similarities in sequence
and oligomeric structure to the bacterial SSBs.
Mitochondrial SSBs (mtSSB) have been isolated from var-
ious organisms. These eukaryotic proteins include a
number of conserved residues that share with E. coli
SSBs in their amino-terminal regions (11–13), but are
divergent otherwise. The putative biological role of
mtSSB is to stabilize single-stranded regions of mitochon-
drial DNA (mtDNA) in the displacement loop (D-loop)
structures and other replicative intermediates (14,15).
Recent biochemical data indicate that TWINKLE, a
DNA helicase at mtDNA replication fork, is speciﬁcally
stimulated by mtSSB (16). Further, mtSSB augments
polymerization rate (17), DNA processivity (18,19), 30-50
exonuclease activity (20), ﬁdelity (18,21) and primer utili-
zation (17,18) of mitochondrial DNA polymerase gamma
(Polg). Together with mtSSB, Polg and TWINKLE form
highly processive replication machinery, capable of gener-
ating DNA products of 16kb (human mtDNA has a
length of 16 568bp) (22,23). In addition, mtSSB is
shown to facilitate packaging mtDNA into bacterial
nucleoid-like structures (24), is required to maintain the
copy number of mtDNA (25,26) and modulates the level
transcription mediated by mitochondrial polymerases
(27). Moreover, expression of mtSSB is regulated in
response to signalling pathways that control mitochon-
drial biogenesis in mammalian cells (26).
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sor p53 plays a novel role in maintaining mitochondrial
genetic stability through its ability to translocate to mito-
chondria and interact physically with mtDNA and the
catalytic subunit of DNA polymerase gamma (PolgA),
in response to mtDNA damage induced by exogenous
and endogenous insults including reactive oxygen species
(ROS) (28). Also known as ‘guardian of the genome’,
p53 is a transcription factor involved in cell-cycle regula-
tion, apoptotic cell death, DNA repair and cellular senes-
cence (29). Being in the centre of a huge network of
proteins that allow integration of various signals, p53 is
activated upon cellular stress such as DNA damage and
the presence of oncogenes. Therefore, interaction of p53
and PolgA is crucial in avoiding accumulation of mtDNA
mutations and preventing mtDNA depletions (28), which
are frequently observed in human cancers (30), ageing
tissues (31,32), mitochondrial diseases (33) and neurode-
generative diseases (34).
In this present report, we showed that tumour suppres-
sor p53 interacts physically with human mtSSB (HmtSSB)
in vitro via its transactivation domain. HmtSSB is a novel
binding partner of p53 in mitochondria and a compo-
nent of mitochondrial DNA replisome. This interaction
is biologically relevant as HmtSSB enhances moderately
the intrinsic 30-50 exonuclease activity of p53, particu-
larly in hydrolysing 8-oxo-7,8-dihydro-20-deoxyguanosine
(8-oxodG) that is a well-known marker of oxidative stress
(35). We propose, therefore, that p53 is implicated in
DNA repair in mitochondria during oxidative stress.
MATERIALS AND METHODS
Nucleic acids
Single-stranded DNAs used for DNA binding of HmtSSB
had the following sequences: 50-[Fluorescein] GTTTTCCC
AGTCACGAC-30 (denoted as 17-mer), 50-[Fluorescein]
AATATGGTTTGTTATAAAGAGTAAAGATTTC-30
(31-mer) and 50-[Fluorescein] GCCCTGATCACGGTACT
CGGTTTTTTTTTTTTTTTTTTTTGGCTCCTCTAGA
CTCGACCG-30 (60-mer). The following hairpin DNAs
were used to test exonuclease activity of p53:
50-[Fluorescein] CCATCTAAGCAGACTCACGAATTC
ACCTAGTTGTTCTAGGTGAAG-30 (hairpinG) and
50-[Fluorescein] CCATCTAAGCAGACTCACGAATTC
ACCTAGTTGTTCTAGGTGAAGG-30 (hairpin2G). The
following 8-oxodG-containing hairpin DNAs were used to
examine exonuclease activity of PolgA, PolgAB2 and p53:
50-[Fluorescein]CCATCTAAGCAGACTCACGACTTCA
CCTAGTTGTTCTAGGTGAA[8-oxodG]-30 (8-oxoG:C)
and 50-[Fluorescein] CCATCTAAGCAGACTCACG
AATTCACCTAGTTGTTCTAGGTGAA[8-oxodG]-30
(8-oxoG:A). All DNAs were HLPC-puriﬁed and were
purchased from either Sigma Genosys or Eurogentec.
Cloning, expression and purification ofHmtSSB, PolcA,
PolcB,p53 and N-terminal domainof p53 (p53N)
HmtSSB. Spodoptera frugiperda Sf9 cells were maintained
and propagated in suspension in TNM-FH insect media
(Sigma–Aldrich) containing 10% (v/v) fetal calf serum
(FCS) and 1% (v/v) lipid, at 278C. Protein expression
was performed by growing 400ml of Sf9 cells to a density
of 1 10
6 cells/ml in suspension. The cells were infected
with 10 plague-forming units/cell of recombinant baculo-
virus. Autographa californica nuclear polyhedrosis virus,
recombinant for HmtSSB expression (mitochondrial
form of the protein without the import signal, residues
17–148), was a generous gift from Prof. Maria
Falkenberg (Karolinska Institute, Stockholm, Sweden).
Infected cells were harvested 72h post-transfection. Cells
were frozen in liquid nitrogen and thawed at 48C in buﬀer
A (50mM Tris–HCl pH 7.6, 0.5mM EDTA, 50mM
NaCl, 1mM DTT) supplemented with DNase, RNase
and protease inhibitor. Cells were lysed by sonication.
Upon centrifugation, supernatant was loaded onto
HiTrap SP FF column (GE Healthcare) pre-equilibrated
with buﬀer A. The ﬂow-through was subsequently re-
loaded onto HiTrap Heparin HP column (GE
Healthcare) pre-equilibrated with buﬀer B [25mM Tris–
HCl pH 7.6, 0.5mM EDTA, 1mM DTT, 10% (v/v) gly-
cerol]. After washing with 5 column volumes (CV) of
buﬀer B, protein was eluted with linear gradient of NaCl
(0–1M) in buﬀer B. Fractions containing HmtSSB were
pooled, concentrated and loaded onto HiLoad 26/60
Superdex 200 column (GE Healthcare) pre-equilibrated
with buﬀer C [25mM Tris–HCl pH 7.6, 0.5mM EDTA,
200mM NaCl, 1mM DTT, 10% (v/v) glycerol]. All chro-
matographic steps were performed at 48C. HmtSSB con-
centration was estimated using an extinction coeﬃcient of
19940M
–1cm
–1.
PolgA. The gene encoding PolgA (mitochondrial form of
the protein without the import signal, residues 26–1240)
was cloned into pFastBac HT A vector (Invitrogen) using
restriction sites BamHI and EcoRI. Recombinant baculo-
virus was produced and ampliﬁed in S. frugiperda Sf9 cells
according to manufacturer’s instructions. PolgA was
expressed and puriﬁed from High Five cells (Invitrogen)
infected with the recombinant baculovirus. Cells were
grown in suspension culture in Ex-Cell 405 medium
(Sigma–Aldrich) supplemented with 5% (v/v) FCS and
1% (v/v) lipid. Cells were harvested on the third day of
infection and lysed by sonication in buﬀer A [50mM Tris–
HCl pH 8, 300mM NaCl, 10mM imidazole, 0.1% (v/v)
2-mercaptoethanol] supplemented with DNase, RNase
and protease inhibitor. After centrifugation, we loaded
supernatant onto HisTrap HP column (GE Healthcare)
pre-equilibrated with buﬀer A. After washing with 5 CV
of buﬀer A, protein was eluted with linear gradient of
imidazole (0.01–1M) in buﬀer A. His-tag was cleaved
with TEV protease overnight. His-tag-removed protein
was diluted with buﬀer B [25mM Tris–HCl pH 8,
0.5mM EDTA, 1mM DTT, 10% (v/v) glycerol] to
adjust NaCl concentration to below 100mM and loaded
onto HiTrap Heparin HP column (GE Healthcare) pre-
equilibrated with buﬀer B. Upon washing with 5 CV of
buﬀer B, protein was eluted with linear gradient of NaCl
(0–1M) in buﬀer B. Fractions containing PolgA were
pooled, concentrated and loaded onto HiLoad 26/60
Superdex 200 column (GE Healthcare) pre-equilibrated
with buﬀer C [25mM Tris–HCl pH 8, 0.5mM EDTA,
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matographic steps were performed at 48C. PolgA concen-
tration was estimated using an extinction coeﬃcient of 241
670M
–1cm
–1.
PolgB. pRUN vector harbouring gene encoding PolgB
(mitochondrial form of the protein without the import
signal, residues 26–486) tagged with 10 His at N-terminal
was a generous gift from Dr Ian J. Holt (MRC Dunn
Human Nutrition Unit, Cambridge, UK). For protein
expression, plasmid was freshly transformed into E. coli
C41 (DE3). Cells were grown in 2 TY media supple-
mented with 100mg/ml ampicillin, at 378C. When
OD600 reached 0.5–0.6, 1mM isopropyl b-D-1-thio-
galactopyranoside (IPTG) was added to induce protein
expression and temperature was lowered to 238C. After
24h, cells were harvested and pellets were frozen in
liquid nitrogen. PolgB was puriﬁed through a sequence
of HisTrap HP column (GE Healthcare), HiTrap
Heparin HP column (GE Healthcare) and HiLoad 26/60
Superdex 200 column (GE Healthcare), as for PolgA with
the exception that His-tag was not cleaved in PolgB.
PolgB concentration was estimated using an extinction
coeﬃcient of 71390M
–1cm
–1.
p53. A superstable mutant of human p53 containing the
following mutations in the core domain: M133L/V203A/
N239Y/N268D was used to increase protein expression
level and sample stability (36,37). Protein expression and
puriﬁcation were performed as described previously (38).
N-terminal domain of p53 (p53N). A gene fragment, cor-
responding to residues 1–93 of human p53, was
PCR ampliﬁed and cloned into pET24a-HLTV vector.
For protein expression, plasmid was freshly transformed
into E. coli C41 (DE3). Cells were grown in 2 TY
media supplemented with 50mg/ml kanamycin, at
378C. When OD600 reached 0.5–0.6, 1mM isopropyl
b-D-1-thiogalactopyranoside (IPTG) was added to
induce protein expression and temperature was lowered
to 258C. After 24h, cells were harvested and pellets were
frozen in liquid nitrogen. Cells were thawed at 48Ci n
buﬀer A [50mM KPi pH 8, 300mM NaCl, 10mM imida-
zole, 1% (v/v) 2-mercaptoethanol] supplemented with
DNase, RNase and protease inhibitor and were lysed
by high-pressure homogenization (EmulsiFlex-C5,
Avestin). After centrifugation, we loaded supernatant
onto HisTrap HP column (GE Healthcare) pre-equili-
brated with buﬀer A. After washing with 5 CV of buﬀer
A, protein was eluted with linear gradient of imidazole
(0.01–1M) in buﬀer A. His-tag+lipoyl domain was
cleaved with TEV protease overnight. The sample was
reloaded onto a second nickel column, after a desalting
step to remove imidazole. The ﬂow-through was diluted
with buﬀer B [50mM KPi pH 8, 5mM DTT, 10% (v/v)
glycerol] to adjust NaCl concentration to  60mM and
loaded onto HiTrap Q HP column (GE Healthcare) pre-
equilibrated with buﬀer B. Upon washing with 5 CV of
buﬀer B, protein was eluted with 1M NaCl in buﬀer B.
Fractions containing p53N were pooled and loaded onto
HiLoad 26/60 Superdex 75 column (GE Healthcare)
pre-equilibrated with buﬀer C [25mM KPi pH 7.2,
150mM KCl, 5mM DTT, 10% (v/v) glycerol]. All chro-
matographic steps were performed at 48C. p53N concen-
tration was estimated using an extinction coeﬃcient of
16500M
–1cm
–1.
15N-labelled sample for NMR was pro-
duced in M9 media using
15NH4Cl as nitrogen source.
Analytical ultracentrifugation (AUC)
Equilibrium sedimentation experiments were performed
on a Beckman XL-I ultracentrifuge by using Ti-60 rotor
and 6-sector cells at speeds of 18000, 25000 and 35000
r.p.m. Data were collected at 158C, following absorbance
at 230nm, 280nm and interference. The sample volume
was 110ml and concentrations tested were 5–100mM.
Buﬀer conditions were 25mM Tris–HCl pH 7.4 and
150mM NaCl. Samples were considered to be at equilib-
rium as judged by a comparison of the several scans at
each speed. Data were processed and analysed by using
UltraSpin software, which is available from our website
(www.mrc-cpe.cam.ac.uk).
Differential scanningcalorimetry (DSC)
Calorimetric measurements were performed by using a
VP-DSC microcalorimeter (MicroCal), equipped with an
AutoSampler. Scans were obtained at a protein concen-
tration of 80mM, in buﬀer containing 25mM HEPES pH
7.4 and 150mM NaCl. A scan rate of 1258C/h was used,
over a temperature range from 2–1108C. The reversibility
of the transition was checked by cooling and reheating the
same sample. Results from the DSC measurements were
analysed with the Origin 7.0 software from MicroCal
using the routines of the software provided with the
instrument (39).
DNA bindingor p53Nbinding ofHmtSSB
The binding of HmtSSB to either ssDNA or p53N was
performed by using ﬂuorescence anisotropy (40,41).
Measurements were recorded on FluoroMax-3 spectro-
ﬂuorimeter (Jobin-Yvon-Horiba) equipped with a
Hamilton Microlab Titrator, at 158C in buﬀer containing
25mM Tris–HCl pH 7.4, 150mM NaCl, and 5mM DTT.
HmtSSB protein was titrated into a cuvette containing
either 1.2-ml ﬂuorescein-labelled ssDNA (initial concen-
tration 1 nM) or AlexaFluor 546-labelled p53N (initial
concentration 100 nM), as described previously (40,41).
Excitation/emission wavelengths for ﬂuorescein and
AlexaFluor 546 were 480/530nm and 540/569nm, respec-
tively. Fluorescence anisotropy was calculated from the
ﬂuorescence intensities (42) and binding analysis was per-
formed using either a simple one-state binding isotherm or
Hill’s equation (40,41).
Intrinsic fluorescence measurements
Intrinsic ﬂuorescence measurements were performed with
a Cary Eclipse ﬂuorescence spectrophotometer (Varian).
Scans were recorded using excitation wavelength of
280nm and emission wavelength ranged from 300 to
400nm. Slit widths for both excitation and emission
were kept at 5nm, with a photomultiplier voltage of
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500 nM, in buﬀer containing 25mM HEPES pH 7.4 and
150mM NaCl.
NMR experiments
Spectra were acquired with a Bruker Avance 700-MHz
spectrometer equipped with a CryoProbe and single-axis
gradients. HSQC spectra (43) were recorded with pro-
tein in a buﬀer of 50mM MES pH 6.8, 100mM NaCl,
5mM DTT and 5% (v/v) D2Oa t2 5 8C. In both
control (
15N-labelled p53N) and sample (
15N-labelled
p53N+HmtSSB) runs, concentrations of p53N and
HmtSSB were  100mM. All spectra were externally refer-
enced based on the position of the water peak.
DNA analysis on denaturing polyacrylamide gel(PAGE)
All polymerization and exonuclease reactions were con-
ducted in buﬀer containing 20mM Tris–HCl pH 7.5,
10mM MgCl2, 2mM ATP, 0.1mg/ml BSA, 1mM DTT
and 10% (v/v) glycerol, at 378C. A ﬁfty-micro-litre reac-
tion mix was quenched by adding 15ml loading dye [8M
urea, 50mM EDTA pH 7.4, 0.01% (w/v) xylene cyanol
FF]. Samples were heated in boiling water for 5min, snap-
cooled in ice water, and analysed on 15% denaturing
PAGE [15% (v/v) acrylamide:bis solution (37.5:1), 7M
urea, 1 TBE] in TBE buﬀer. Gels were run at constant
power of 10W for 60–70min, at room temperature. Gel
images were acquired with Typhoon scanner (GE
Healthcare) and analysed with ImageQuant TL software
(GE Healthcare).
Confocal immunofluorescence microscopy
Human 143B TK- osteosarcoma cells were grown and
maintained in Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM+GlutaMax-1, Invitrogen), supplemented with
10% FCS. Cells were sub-cultured at a ratio of 1:8 in
standard 6-well plate and cells were grown on glass cover-
slips overnight. Media were replaced with either fresh
DMEM media, DMEM supplemented with rotenone
(100nM/500nM) or DMEM supplemented with H2O2
(50mM/250mM). After 24 or 48h, cells were washed two
times with serum-free DMEM, followed by incubation
with MitoTracker Orange (1mM in serum-free DMEM)
for 15min at room temperature. After mitochondria stain-
ing, cells were washed three times with serum-free DMEM
and once with PBS. Cells were ﬁxed for 20min with
4% (w/v) paraformaldehyde in PBS, and permeabilized
by washing three times with PBS+0.1% (v/v) Triton
X-100 (TX100). For blocking, the coverslips were incu-
bated for 30min with PBS+0.1% (v/v) TX100+1%
(w/v) BSA and incubated for 1h with primary antibodies
(mouse anti-DNA, diluted 1:20 in blocking solution and/
or rabbit anti-p53, diluted 1:200 in blocking solution;
PROGEN Biotechnik GmbH). Coverslips were then
washed three times with PBS + 0.1% TX100 and incu-
bated for 1h with secondary antibodies (AlexaFluor 647
goat anti-mouse IgG and/or AlexaFluor 488 goat anti-
rabbit IgG, both diluted 1:1000 in blocking solution;
Molecular Probes). Coverslips were again washed three
times with PBS+0.1% TX100, air-dried and mounted
in Fluoromount-G (SouthernBiotech). All steps were per-
formed in the dark. Images were collected on a BioRad
Radiance confocal microscope.
RESULTS
HmtSSB was over-expressed in insect cells (S. frugiperda,
Sf9). The advantage of using baculoviral expression
system in this case was to avoid cross-contamination
from constitutively expressed E. coli SSB, since both
HmtSSB and E. coli SSB have analogous physiochemical
properties (44). We characterized the oligomeric structure,
thermostability and DNA-binding properties of insect
cell-expressed HmtSSB as a prelude to the study of phy-
sical/functional interactions between HmtSSB and p53.
HmtSSB isathermostable tetramer
In order to analyse the DNA-binding and p53N-binding
of HmtSSB, it was ﬁrst necessary to determine the oligo-
merization state of insect cell-expressed HmtSSB in solu-
tion. Using equilibrium sedimentation AUC, we showed
that HmtSSB existed as homotetramers in solution for all
concentrations tested (5, 10, 25, 50, 75 and 100mM). The
data were ﬁtted to a single exponential model (Figure 1),
using partial speciﬁc volume of 0.7340 for HmtSSB and
solvent density of 1.006 (both values were calculated using
Sednterp software). An apparent molecular weight of
59.2 (±0.3) kDa was obtained, which is 3.9 times the
size of a monomer (15.2kDa). Therefore, HmtSSB (each
monomer of the mitochondrial form has 132 amino acids,
tetrameric size=60.8kDa) shares the same oligomeric
structure as E. coli SSB (each monomer has 178 amino
acids, tetrameric size=75.9kDa) (7), and diﬀers consid-
erably from heterotrimeric replication protein A (RPA,
a nuclear SSB) (9).
Figure 2 shows the DSC thermogram for HmtSSB
(80mM) at pH 7.4 (25mM HEPES buﬀer). The thermo-
gram was asymmetrical, in agreement with the multimeric
nature of the protein. Apparent Tm of HmtSSB is  828C.
Similar to E. coli SSB (45,46) and murine mtSSB (47),
HmtSSB is a thermostable protein. Thermogram of
HmtSSB did not show any characteristic signs of heavily
aggregated protein, after heat denaturation. Further,
HmtSSB denatured irreversibly, as judged from the
rescan thermogram.
HmtSSB binds ssDNA tightly and cooperatively
Using ﬂuorescence anisotropy, we performed solution-
based DNA-binding experiments to measure the aﬃnity
of tetrameric HmtSSB to ssDNAs. In contrast to radioac-
tivity based electrophoretic mobility shift assay (EMSA)
that is commonly employed to study DNA-binding of
SSBs qualitatively (19,47), ﬂuorescence anisotropy
allows quantitative measurement of DNA aﬃnity. Three
ssDNAs of diﬀerent lengths (17-mer, 31-mer and 60-mer)
were used and their sequences were optimized to minimize
DNA secondary structure formation (Supplementary
Figure S1A). Increasing concentrations of HmtSSB were
titrated automatically to a sample of ﬂuorescently labelled
DNA (1nM) and DNA-binding experiments were
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data from 17-mer experiments ﬁtted well to a simple one-
state model (Figure 3A), yielding dissociation constant
(Kd) of 19.2 (±3.1) nM (Table 1). The same model
could not be applied to ﬁt data from 31-mer and 60-mer
experiments. These data, however, were ﬁtted well to the
Hill equation indicating cooperativity in binding longer
ssDNAs (Figure 3B). Upon curve ﬁtting, we obtained Kd
and Hill constant of 1.5 (±0.3) nM and 1.9 (±0.2),
respectively, for 31-mer (Table 1). In experiments invol-
ving 60-mer ssDNA, similar Kd (1.4±0.4 nM) and Hill
constant (2.0±0.3) were obtained (Table 1). Thus,
HmtSSB binds  13-fold tighter to longer ssDNA
(31-mer and 60-mer) than to shorter ssDNA (17-mer).
Interestingly, strong cooperativity was also observed for
17-mer, when DNA concentration was increased signiﬁ-
cantly above Kd value (data not shown). All dissociation
Figure 3. Binding titration proﬁles of HmtSSB with ﬂuorescein-labelled
single-stranded DNAs. (A) HmtSSB binding to 17-mer. (B) HmtSSB
binding to 31-mer (ﬁlled diamond) and 60-mer (ﬁlled square).
Experiments were conducted at 158C in 25mM Tris–HCl pH 7.4,
150mM NaCl and 5mM DTT.
Figure 1. (A) Equilibrium sedimentation AUC of HmtSSB (5mM) at
speeds of 18000 r.p.m. (times), 25000 r.p.m. (open circle) and 35000
r.p.m (plus). Data were ﬁtted to a single-exponential model (smooth
line). Experiments were conducted at 158C in 25mM Tris–HCl pH 7.4
and 150mM NaCl. (B) Residuals of curve ﬁts.
Figure 2. DSC thermograms of HmtSSB (80mM) in buﬀer containing
25mM HEPES pH 7.4 and 150mM NaCl (solid line), of buﬀer (dashed
line) and of sample rescan (dotted line).
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HmtSSB concentrations for the convenience of comparing
aﬃnities from various studies, estimated using diﬀerent
approaches, particularly EMSA.
HmtSSB contains two tryptophan residues at positions
65 and 84 (correspond to positions 49 and 68 in the mito-
chondrial form of the protein). From sequence compari-
son, these residues are homologous to the tryptophan
residues 41 and 55 of E. coli SSB (NCBI accession code
P0AGE0) (48). Figure 4 shows the intrinsic ﬂuorescence
spectra of HmtSSB, in the absence and presence of ssDNA
(17-mer or 60-mer). Excitation at 280nm gave an emission
maximum at 352nm, implying that these tryptophan resi-
dues are solvent exposed. Upon binding 17-mer, the ﬂuo-
rescence emission of HmtSSB was reduced by  70%.
When longer ssDNA was used (60-mer), there was
 90% loss in ﬂuorescence emission. These results corro-
borated previous observations on E. coli SSB, that Trp 41
and Trp 55 are involved in stabilizing protein-nucleic acid
complexes via stacking interactions with the nucleotide
bases of ssDNA (48–52). Consistent with the spectro-
scopic data, crystal structure of E. coli SSB bound to
two 35-mer ssDNA provides clear evidence that Trp 41,
Trp 54 and Phe 61 make extensive interactions with
ssDNA (53).
HmtSSB binds N-terminal domainof p53 (p53N)
Upon DNA damage, the tumour suppressor p53 is acti-
vated and orchestrates a cellular response by transcrip-
tional regulation of genes or by interacting with other
proteins involved in cell-cycle arrest, apoptosis, senescence
and DNA repair. One of these protein partners is RPA, a
nuclear SSB, which binds p53 transactivation domain
(54,55). Accumulating evidence indicates that p53 is also
able to translocate to mitochondria and interacts physi-
cally with mitochondrial proteins, such as PolgA (28) and
mitochondrial transcription factor A (TFAM) (56). On
the basis of these previous ﬁndings, we hypothesized
that HmtSSB could interact with p53 and possibly via
its transactivation domain. By using ﬂuorescence aniso-
tropy, we assayed HmtSSB for binding to an AlexaFluor
546-labelled p53N (residues 1–93) at physiological ionic
strength and our hypothesis was indeed veriﬁed. Data
were ﬁtted to a simple one-state model, yielding a Kd of
12.7 (±0.7) mM (Figure 5A). The binding mode of p53N
to HmtSSB and/or binding site on HmtSSB is plausibly
identical to a short ssDNA, in view of the acidic nature of
p53N (pI=3.47). To test this assumption, we performed a
competition assay. Non-ﬂuorescently-labelled 17-mer
ssDNAs were titrated into a mixture of 100 nM
AlexaFluor 546-labelled p53N and 20mM HmtSSB. The
decrease in anisotropy indicated displacement of p53N
from HmtSSB (Figure 5B). HmtSSB bound 17-mer
 661-fold tighter than it did p53N. Nevertheless, aniso-
tropy dropped to a minimum level at 17-mer concentra-
tion of  8mM suggesting the possibility that HmtSSB
could bind p53N and 17-mer simultaneously. This is not
surprising as four possible binding sites exist in one tetra-
meric HmtSSB molecule. In the case of nuclear SSB
(RPA), p53N binding site also overlaps with ssDNA-
binding region (55). We did not measure the intrinsic
ﬂuorescence of HmtSSB upon binding p53N, as three
solvent-exposed tryptophans (Trp 23, Trp 53 and
Trp 91) exist in p53N.
Table 1. Binding of ssDNAs (17-mer, 31-mer and 60-mer) and p53N (residues 1–93) to HmtSSB, measured using ﬂuorescence anisotropy
DNA/p53N Simple one-state model Hill equation
a Number of titrations
repeated
Kd (M) Kd (M) Hill constant
17-mer 19.2±3.1 (10
 9) 19.4±4.0 (10
 9) 1.1±0.3 4
31-mer Poor ﬁt 1.5±0.3 (10
 9) 1.9±0.2 3
60-mer Poor ﬁt 1.4±0.4 (10
 9) 2.0±0.3 4
p53N 12.7±0.7 (10
 6) 14.2±0.3 (10
 6) 0.9±0.0 3
DNAs and p53N were labelled with 50-ﬂurescein or AlexaFluor 546, respectively. Data were ﬁtted to either a simple one-state model or Hill equation.
All dissociation constants were expressed as HmtSSB monomer concentrations.
aHill equation: Protein ½ 
h= Kh
d þ Protein ½ 
h 
where h is Hill constant.
Figure 4. Intrinsic ﬂuorescence emission spectra of HmtSSB in the
absence (green) and presence of 17-mer (orange) and 60-mer (purple),
at excitation wavelength of 280nm. Experiments were conducted at
25
8C in 25mM HEPES pH 7.4 and 150mM. Concentrations of both
HmtSSB and single-stranded DNAs were 500 nM. Control spectra
without HmtSSB were also recorded: buﬀer (black), 17-mer in buﬀer
(red) and 60-mer in buﬀer (red).
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NMR HSQC spectra of
15N-labelled p53N (100mM) in
the absence and presence of unlabelled HmtSSB
(100mM). In Figure 6, free
15N-labelled p53N spectrum
(red) was overlaid with the HmtSSB-bound spectrum
(blue). p53N interacts clearly with HmtSSB through an
extended interface. Large chemical shift perturbations
were mainly localized in three regions: region I (residues
20–28), region II (residues 35–40) and region III (41–59).
Resonances at Leu 26, Trp 53, Phe 54, Thr 55 completely
disappeared in the bound spectrum, signifying the impor-
tance of hydrophobic interaction in stabilizing p53N-
HmtSSB complexes. The p53 transactivation domain is
subdivided into two loosely deﬁned subdomains (57,58),
TAD1 (residues 1–40) and TAD2 (residues 41–61). Most
p53N-binding proteins reported to date, in general, bind
to either one of the two transactivation subdomains.
Proteins like MDM2 (59), MDM4 (60), TBP (61),
TAFII31 (62), TAFII40 (63) and TAFII60 (63) all interact
with TAD1, whereas RPA (54,55) and p62/Tfb1 subunit
of TFIIH (64,65) bind to TAD2. We found that HmtSSB
interacts simultaneous with TADI and TAD2, similar to
the transcriptional coactivator p300 (66).
PolcA, butnot PolcAB2, is capable ofhydrolysing 8-oxodG
Being at the site of cellular respiration (oxidative phos-
phorylation), mtDNA is particularly vulnerable to reac-
tive oxygen species (ROS) that are by-products of normal
metabolism. The levels of 8-oxo-7,8-dihydro-20-deoxygua-
nosine (8-oxodG), an indicator of oxidative DNA
damage, were 4-fold higher in mtDNA compared with
nuclear DNA in heart tissue obtained from eight mamma-
lian species with varying life spans (3.5 to 46yr) (67).
Further, there was a signiﬁcant inverse correlation
Figure 5. (A) Binding titration proﬁle of HmtSSB with AlexaFluor 546-
labelled p53N (residues 1-93). (B) Competition assay in which non-
ﬂuorescently labelled 17-mer was titrated into a mixture of 100 nM
AlexaFluor 546-labelled p53N and 20mM HmtSSB. The decrease in
ﬂuorescence anisotropy indicated displacements of p53N from
HmtSSB. Experiments were conducted at 158C in 25mM Tris–HCl
pH 7.4, 150mM NaCl and 5mM DTT.
Figure 6. NMR HSQC spectra of
1H
15N-labelled p53N (residues 1–93,
100mM) in the absence (red) and presence of 100mM of HmtSSB
(blue). Spectra were recorded at 258C in 50mM MES pH 6.8,
100mM NaCl, 5mM DTT and 5% (v/v) D2O.
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span among the diﬀerent species (67). 8-oxodG is capable
of base-pairing with both 20-deoxycytidine (dC) and
20-deoxyadenosine (dA) (68). The 8-oxodG:dC pair
mimics natural dG:dC pair, whereas 8-oxodG:dA pair
results in GC!TA transversions (69,70). Transversions
usually cause non-synonymous amino acid substitutions,
if not repaired (71).
The interaction between p53 and SSB (e.g. RPA) has
been implicated in DNA repair (72). Since p53 was shown
to translocate to mitochondria upon oxidative stress,
we decided to examine the exonuclease activities of Polg
and p53 using oxidized DNAs. In this experiment, we
designed two DNAs containing 8-oxodG at 30-termini
(Supplementary Figure S1B). The sequences of DNAs
were optimized so that the DNAs form hairpins sponta-
neously, with double-stranded stem at 30-end and single-
stranded arm at 50-end. These DNAs mimic singly primed
template, useful for studying 30-mismatch hydrolysis and
template-directed polymerization. An obvious advantage
of using such DNAs is keeping ‘primer’ and ‘template’ at
right stoichiometric ratio. One of our two DNAs had
8-oxodG:dC pair at 30-end (denoted as 8-oxoG:C), while
8-oxodG:dA pair was present at 30-end of the other DNA
(8-oxoG:A).
Polg, exists as a heterotrimer in mitochondria
(PolgAB2), comprising a catalytic subunit (PolgA) and
two accessory subunits (PolgB). PolgA and PolgB were
expressed in insect cells and E. coli, respectively. Both
proteins were functional, as veriﬁed using various bio-
chemical and biophysical assays (data not shown).
PolgA could eﬀectively hydrolyse 30-end 8-oxodG in
both 8-oxoG:C and 8-oxoG:A in the absence of dNTP
(Figure 7A). An obvious diﬀerence in comparing the deg-
radation patterns of 8-oxoG:C and 8-oxoG:A was the
extent of inward digestion. In 8-oxoG:C, exonuclease
activity of PolgA proceeded further, generating smaller
DNAs. When encountering 8-oxodG:dA mismatch, exo-
nuclease activity of PolgA paused at position after
8-oxodG was removed from 30-end. The result was in
good agreement with another set of experiments, in
which non-oxidized DNAs were used (data not shown).
Exonuclease activity of PolgA was ‘progressive’ when
incubated with 30-matching DNA and ‘stalling’ when
mixed with 30-mismatching DNA, in the absence of
dNTP. In the presence of dNTP, PolgA catalysed poly-
merization in both 8-oxoG:C and 8-oxoG:A. Surprisingly,
both exonuclease and polymerization activities of PolgA
were inhibited after complexing with PolgB when oxidized
DNAs were used (Figure 7A), which was not observed in
non-oxidized DNAs (data not shown). We speculated that
mtDNA replication was hindered, upon prolonged oxida-
tive stress exposure. We veriﬁed this assumption using
confocal microscopic analysis. Human 143B TK- osteo-
sarcoma cells were incubated with rotenone (100nM/
500nM) and H2O2 (50mM/250mM) for 24 and 48h.
Rotenone, a complex I inhibitor, is known to increase
mitochondrial ROS by interfering with the respiratory
activity (73). After drug treatment, mitochondria were
stained with MitoTracker Orange and mtDNA was
detected with combination of mouse anti-DNA and
AlexaFluor 647 goat anti-mouse IgG. 24-h incubation
did not result in evident diﬀerences (Supplementary
Figure S2), even at 500 nM rotenone and 250mMH 2O2.
A drastic mtDNA reduction was noticed after 48h, at
both 100 nM rotenone and 50mMH 2O2 (Figure 8). The
same experiment was repeated three times independently.
We conﬁrmed that the mtDNA reduction was neither
experimental error nor cell-staining artefact.
Intrinsic3’-5’ exonuclease activity of p53 iscapable of
excising8-oxodG
Other than its transcriptional activity, p53 possesses
intrinsic 30-50 exonuclease activity (74–79). Using two
non-oxidized DNAs (hairpinG with one dG:dA mismatch
at 30-end and hairpin2G with two consecutive dG:dA mis-
matches at 30-end, see Supplementary Figure S1C), we
conﬁrmed that full-length p53 is a weak 30-50 exonuclease
in the presence of Mg
2+ ions (Figure 7B). Same DNAs
were tested with PolgA. Both exonuclease and polymerase
activities of PolgA were positive (Supplementary
Figure S3). We excluded the possibility that the observed
p53 exonuclease activity was due to contaminating pro-
teins co-puriﬁed with p53. C-terminal truncated p53 or
DNA-binding domain of p53, puriﬁed using exact puriﬁ-
cation scheme, did not show noticeable exonuclease activ-
ity (data not shown). This concern was also addressed by
other authors and same conclusion was drawn (74).
Figure 7. (A) Exonuclease activities of PolgA, PolgAB2 and full-length
p53 using two hairpin DNAs containing 8-oxodG at 30-termini
(denoted as 8-oxoG:C and 8-oxoG:A). (B) Exonuclease activities of
full-length p53 using two hairpin DNAs containing one dG:dA mis-
match (left) or two dG:dA mismatches (right) at 30-termini.
Experiments were conducted at 378C in 20mM Tris–HCl pH 7.5,
10mM MgCl2, 2mM ATP, 0.1mg/ml BSA, 1mM DTT and 10%
(v/v) glycerol. DNA samples were analysed on 15% denaturing
PAGE in 1   TBE.
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8-oxodG in 8-oxoG:C and 8-oxoG:A DNAs, both in a
‘progressive’ manner (Figure 7A).
HmtSSB enhances exonuclease activity of p53 moderately
We next checked the eﬀect of HmtSSB on the exonuclease
activity of p53, as HmtSSB was previously demonstrated
to augment 30-end mismatch hydrolysis of Polg (20).
Figure 9 exempliﬁed that 30-end 8-oxodG hydrolysis of
p53 was enhanced moderately by addition of HmtSSB,
particularly in ‘mismatching’ 8-oxoG:A DNA. The diﬀer-
ence in DNA hydrolysis was not due to unequal DNA
sample loading to denaturing PAGE. Experiment was
repeated and same result was observed. We reckoned
that p53-HmtSSB complex had higher aﬃnity towards
non-speciﬁc DNA, in comparison to p53 alone. This
might account for enhanced p53 exonuclease activity.
DISCUSSION
The binding modes ofssDNA and p53Nto HmtSSB
Escherichia coli SSB exhibits two types of cooperative
ssDNA-binding behaviours (80). At low ionic strength
(<10mM NaCl) (81,82) and high protein:DNA ratio
(83–85), E. coli SSB displays ‘unlimited’ cooperative
binding to long ssDNA, resulting in long protein clusters
(83,85). At high ionic strength (>200mM NaCl or
Figure 8. Confocal microscopic analyses of human 143B TK- cells after incubating with 100 nM rotenone or 50mMH 2O2 for 48h. Mitochondria
were stained with MitoTracker Orange and mtDNA were probed with combination of mouse anti-DNA and AlexaFluor 647 goat anti-mouse IgG.
576 Nucleic Acids Research, 2009, Vol. 37,No. 23mM MgCl2) (81,82) and low protein:DNA ratio (83–85),
‘limited’ cooperativity is favoured in which the protein
does not form long clusters along ssDNA. Two binding
modes have previously been deﬁned for E. coli SSB,
referred as (SSB)35 and (SSB)65 (83,85). The diﬀerence
between these two modes lies in the number of nucleotides
occluded per bound tetramer [35±2 for (SSB)35 and
65±3 for (SSB)65]. In (SSB)35, two of the four E. coli
SSB monomers are in contact with ssDNA, while in
(SSB)65, all four E. coli monomers are contacting
ssDNA (81,82,86). Therefore, ‘unlimited’ cooperativity is
thought to be associated with (SSB)35 mode (80,83,85)
whereas (SSB)65 promotes ‘limited’ cooperativity
(80,83,84).
In the present study, we reported ssDNA- and p53N-
binding of human mitochondrial SSB, at physiological
ionic strength (150mM NaCl). Based on the data from
ﬂuorescence anisotropy and intrinsic ﬂuorescence
measurements, we proposed the binding models
depicted in Figure 10. For the 17-mer, we expected a
(DNA)1:(tetramer)1 ratio since binding data ﬁtted well to
a simple one-state model (Figure 3A). When DNA con-
centration was increased, we observed cooperative beha-
viour (data not shown) which could be explained by
additional 17-mer bound to the same tetramer. In
either (DNA)1:(tetramer)1 or (DNA)2:(tetramer)1, not all
monomers are in contact with ssDNA because of the lim-
ited length of ssDNA. This is consistent with the 30%
intrinsic ﬂuorescence retained upon binding 17-mer
(Figure 4). As such, the (SSB)35 mode is dominant in bind-
ing short ssDNA. For 31-mer and 60-mer, we suggested
(DNA)2:(tetramer)1 based on four pieces of evidence:
Firstly, binding data ﬁtted well to the Hill equation yield-
ing a Hill constant of 2 (Figure 3B). Secondly, only  10%
of intrinsic ﬂuorescence was retained upon binding 60-mer
suggesting that most monomers are contacting ssDNA
(Figure 4). Thirdly, each ssDNA was bound to two mono-
mers and this explains higher aﬃnity ( 13-fold) of
HmtSSB for longer ssDNA. Fourthly, the crystal struc-
ture of E. coli SSB is bound to two 35-mers indicating
(DNA)2:(tetramer)1 (53). Thus, the (SSB)65 binding
mode is favoured in binding long ssDNA (35-mer and
60-mer). It has previously been demonstrated that two
murine mtSSB tetramers can bind simultaneously to an
80-mer, when the complex is formed in buﬀer containing
10mM Tris–HCl pH 8.0, 2mM DTT and 200mg/ml BSA
(19). We believe that this binding mode was impossible for
human mtSSB, based on two compelling reasons. Firstly,
HmtSSB aggregated upon dialysis into NaCl-free buﬀer
(data not shown). Other authors have also reported that
HmtSSB was insoluble at salt concentrations lower than
50mM NaCl (44). Secondly, we performed equilibrium
sedimentation AUC using a mixture of ﬂuorescein-
labelled 60-mer (5mM) and HmtSSB (107mM). Data
were collected by monitoring ﬂuorescein absorbance at
492nm, at 12000, 17000 and 24000 r.p.m. Upon data
Figure 9. Exonuclease activities of full-length p53 using two hairpin
DNAs containing 8-oxodG at 30-termini (denoted as 8-oxoG:C and
8-oxoG:A), in the absence and presence of HmtSSB. Experiments
were conducted at 37
8C in 20mM Tris–HCl pH 7.5, 10mM MgCl2,
2mM ATP, 0.1mg/ml BSA, 1mM DTT and 10% (v/v) glycerol. DNA
samples were analysed on 15%denaturing PAGE in 1   TBE.
Figure 10. Schematic models of 17-mer/HmtSSB, 60-mer/HmtSSB and
p53N/HmtSSB interactions. HmtSSB exists as homotetramer in solu-
tion. 17-mer and p53N bind to HmtSSB in (DNA)1:(tetramer)1 and
(p53N)1:(tetramer)1 ratios. 60-mer binds cooperatively to HmtSSB, in
either (DNA)2:(tetramer)1 or (DNA)1:(tetramer)1. In 17-mer/HmtSSB
or p53N/HmtSSB interactions, not all HmtSSB monomers are in con-
tact with binding partners, whereas in 60-mer/HmtSSB, all monomers
are contacting binding partners.
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Figure 4) using partial speciﬁc volume of 0.6443 for
(DNA)2:(tetramer)1 complex and solvent density of
1.006, we found an apparent molecular weight of 81.8
(± 0.9) kDa. The discrepancy between this value and
calculated molecular weight (Mw) for
(DNA)2:(tetramer)1 complex (98.6kDa) results from diﬃ-
culty in estimating partial speciﬁc volume for protein–
DNA complex. Certainly, no high-molecular-weight spe-
cies [Mw of (DNA)1:(tetramer)2 complex is calculated to
be 145.5kDa] was observed. Nonetheless, we could not
exclude the possibility that a 60-mer could wrap around
the outside of the entire tetramer to give a
(DNA)1:(tetramer)1 complex. The calculated Mw of
(DNA)1:(tetramer)1 complex (79.7kDa) was also closed
to the apparent Mw from AUC (91.6±1.1kDa), when
data were ﬁtted using partial speciﬁc volume of 0.6785
for (DNA)1:(tetramer)1 complex. In the case of p53N-
binding, (p53N)1:(tetramer)1 complex was proposed since
binding data were well-ﬁtted to a simple one-state binding
model. Moreover, it is plausible that p53N and ssDNA
can bind simultaneously to HmtSSB tetramer which
accounts for the enhanced 30-50 exonuclease activity of
p53 (Figure 9).
p53translocation to mitochondria
p53 is a predominantly nuclear protein, lacking a mito-
chondrial targeting sequence as predicted using Mitoprot
software (http://ihg2.helmholtz-muenchen.de/ihg/mito-
prot.html). It has been shown that the cytoplasm con-
tained a separate and distinct p53 pool that was the
major source for p53 translocation to the mitochondria
upon its stress-induced stabilization (87). Albeit not a
p53-shuttler, Mdm2 was required for monoubiquitylation
of p53 and thus its translocation to mitochondria (87).
Upon arrival at the mitochondria, p53 underwent rapid
deubiquitylation by mitochondrial HAUSP via a stress-
induced mitochondrial p53-HAUSP complex (87). This
generated apoptotically active and non-ubiquitylated
mitochondrial p53 (87). Nonetheless, contrasting data
exist suggesting that mitochondrial p53 originated from
nucleus and utilized p53 ubiquitylation for mitochondrial
targeting (88). The mechanism by which p53 is translo-
cated to mitochondria remains to be clariﬁed.
Mitochondrial p53 was demonstrated to be highly eﬃ-
cient in inducing the release of soluble (e.g. cyto C, Smac)
and non-soluble (e.g. AIF, EndoG; both tethered to the
inner mitochondrial membrane) apoptogenic factors by
severely disrupting the integrity of both outer as well as
inner mitochondrial membranes (89). This action was
associated with p53-induced oligomerization of Bax,
Bak and VDAC, and the formation of stress-induced
endogenous p53-cyclophilin D complex located at the
inner membrane (89). Therefore, mitochondrial mem-
brane permeabilization triggered by p53 is a highly plau-
sible mechanism by which p53 enters mitochondrial
matrix where p53 binding partners (e.g. PolgA, TFAM,
HmtSSB) are located. Alternatively, p53 could possibly be
imported via mitochondrial translocon since p53 has been
shown to interact with two key mitochondrial import
proteins, mtHsp70 and Hsp60 (88). Recent ﬁndings fur-
ther documented that many nuclear proteins were loca-
lized in mitochondrial matrix and directly involved
in mitochondrial functions, without harbouring typical
N-terminal mitochondrial leader sequence. These include
nuclear triiodothyronine receptor (c-ErbAa1) (90), reti-
noic acid X receptor [(RXR)a] (90) and estrogen receptor
(ERa and b) (91).
In mammalian cells, mtDNA replication takes place
preferentially within a subset of mitochondria clustered
within a perinuclear domain (92). Interestingly, HmtSSB
protein is also not distributed uniformly within all mito-
chondria but is more abundant within perinuclear regions
(26). In other words, nuclear p53 is located in close prox-
imity to mitochondrial protein partners (e.g. PolgA and
HmtSSB).
Biological implication of p53-HmtSSB interaction
p53 function is directly related to its transcriptional activ-
ity, mediated through sequence-speciﬁc binding to several
DNA targets in the genome. The consensus DNA-binding
site comprises two decameric repeats of the general form
PuPuPuC(A/T)(A/T)GPyPyPy separated by 0 13bp
(93,94). In addition to its DNA binding capacity, the
p53 core domain has an intrinsic 30-50 exonuclease activity
(75) that is modulated by its C-terminus (74,95). This exo-
nuclease activity has been suggested to be involved in
DNA damage repair (96). We showed that full-length
p53 is a weak 30-50 exonuclease (Figure 7). When tetramer-
ization domain and C-terminal regulatory domain were
truncated, p53 is devoid of exonuclease activity (data
not shown). Unlike PolgAB2, p53 is capable of hydrolys-
ing 30-end 8-oxodG and this activity is enhanced moder-
ately by addition of HmtSSB (Figure 9). A possible
explanation for the increased mismatch hydrolysis is that
HmtSSB augments aﬃnity of p53 towards non-speciﬁc
DNA.
Although p53/HmtSSB interaction is relatively weak
(Kd = 12.7±0.7mM), concentration of HmtSSB within
mitochondria is high (97,98). In human HeLa cells,
HmtSSB is 3000-fold more abundant than mtDNA (97).
Depending on physiological conditions, the size of mito-
chondria varies from 0.5mmt o1 0 mm. Each mitochon-
drion contains about 2–10 copies of mtDNA. Taken
together and assuming spherical shape of mitochondrion,
the calculated HmtSSB concentration ranges from 19nM
to 762mM. It is important to note that mitochondrial p53
isolated from ML1, HCT116 and RKO cells, after short
term genotoxic stress, were phosphorylated on Ser 6, Ser
9, Ser 15, Ser 20, Ser 37 and Ser 46, even though phos-
phorylation/acetylation are not determining factors for
p53’s translocation to mitochondria (99). These serine
residues were located within TAD1 (residues 1–40) and
TAD2 (residues 41–61) regions of p53, the identiﬁed bind-
ing interface between p53 and HmtSSB. Since phosphor-
ylation increases negative charge on p53N-terminal, we
believe that the aﬃnity between p53/HmtSSB in vivo is
higher than value obtained from in vitro measurement.
Remarkably, when the human mitochondrial genome
(NC 001807) was inspected for putative p53-recognition
578 Nucleic Acids Research, 2009, Vol. 37,No. 2sequences, a total of seven candidate sequences were
detected: 1553, 1809, 2397 and 2903 positioned within
the 12S and 16S rDNA region downstream of the heavy
strand promoter; 4637 situated within NADH dehydro-
genase subunit 2 gene; 12230 positioned between
NADH dehydrogenase subunit 4 and 5 genes; and 16
190 lying within the regulatory D-loop downstream of
the light strand promoter (the numbers indicate the posi-
tions of the ﬁrst nucleotide of the recognition sequence)
(100). Of these, recognition sequence 1553 conferred
responsivity to p53 and p530s relatives p73a and b (100).
It was, therefore, suggested that mitochondrial p53 might
bind directly to mtDNA and perhaps be involved in the
regulation of mitochondrial transcription/replication. In
addition, the presence of mtDNA likely enhances further
p53/HmtSSB interaction. This is made possible since p53/
mtDNA interaction (via DNA-binding core domain and
possibly C-terminal regulatory domain) and p53/HmtSSB
interaction (via N-terminal transactivation domain)
involve diﬀerent functional domains of p53. Likewise for
HmtSSB, simultaneous HmtSSB/p53 and HmtSSB/
mtDNA interactions is feasible due to its multimeric
nature. Our data has shown that p53 is implicated in
maintaining mitochondrial genome stability. In addition
to p53, we believe other proteins are recruited for mtDNA
repair during oxidative stress since p53 is a weak exonu-
clease compared to PolgA. This explains drastic mtDNA
loss in 143B cells, after a 48-h incubation with oxidizing
agents (Figure 8). In sum, we propose that mitochondrial
p53 plays dual roles: an initiator of a cascade of apoptosis
program and a mtDNA repair factor upon cellular stress.
CONCLUSION
In the present study, we identiﬁed HmtSSB as a novel
binding partner of tumour suppressor p53 in mitochon-
dria. Biophysical measurements, in combination with bio-
chemical assays, provide a systematic platform to
characterize the physical and functional interactions
between these two proteins in vitro. The validation of
this binding in vivo would, of course, require additional
cell-based experiments.
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